Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      Cama Hospital: Tata Trust grants Rs 3 crore to restore building, build museum

      Cama Hospital: Tata Trust grants Rs 3 crore to restore building, build museum

      Farhat Nasim16 Jan 2019 4:22 PM IST
      Mumbai: In order to keep the history alive and keep things rolling in the city's oldest hospital, the Cama & Albless Hospital has been granted a...
      Fortis completes acquisition of RHT assets at enterprise value of Rs 4650 crore

      Fortis completes acquisition of RHT assets at enterprise value of Rs 4650 crore

      Farhat Nasim16 Jan 2019 1:13 PM IST
      In February last year, Fortis had announced that it has entered into definitive agreements with RHT to acquire entire portfolio of assets of the...
      TAVR: Edward Lifesciences pays Boston Scientific $180 million to end patent dispute

      TAVR: Edward Lifesciences pays Boston Scientific $180 million to end patent dispute

      Farhat Nasim16 Jan 2019 9:45 AM IST
      The valves are used in a relatively new procedure called transcatheter aortic valve replacement, or TAVR, in which the original heart valve is not...
      Walgreens and Microsoft enters seven years agreement to develop digital healthcare services

      Walgreens and Microsoft enters seven years agreement to develop digital healthcare services

      Farhat Nasim16 Jan 2019 9:30 AM IST
      Microsoft will become Walgreens' cloud provider through the agreement and the Microsoft 365 software will be rolled out to more than 380,000 Walgreens...
      Twitter had a field day when Biocon founder got stuck in a traffic jam

      Twitter had a field day when Biocon founder got stuck in a traffic jam

      Farhat Nasim15 Jan 2019 5:44 PM IST
      Bengaluru: Twitteratis flooded with their opinion on traffic after Biocon founder, Kiran Mazumdar Shaw's tweet wherein she expressed her perception...
      Seven Hills Hospital sale to UAE billionaire objected by founder Maganti: Report

      Seven Hills Hospital sale to UAE billionaire objected by founder Maganti: Report

      Farhat Nasim15 Jan 2019 2:01 PM IST
      Mumbai: The Seven Hills Hospital deal is likely to head towards another controversy with reports that its founder, Jitendra Maganti, has filed...
      Abbot receives USFDA approval to Amplatzer Piccolo Occluder, smallest infant device to treat congenital heart defects

      Abbot receives USFDA approval to Amplatzer Piccolo Occluder, smallest infant device to treat congenital heart defects

      Farhat Nasim15 Jan 2019 9:30 AM IST
      The Amplatzer Piccolo Occluder is a self-expanding, wire mesh device that is inserted through a small incision in the leg and guided through vessels...
      Pfizer shutdown at Chennai, Aurangabad: Employees offered Severance Package

      Pfizer shutdown at Chennai, Aurangabad: Employees offered Severance Package

      Farhat Nasim14 Jan 2019 2:06 PM IST
      Chennai: While shutting down plants at two major cities in the country, drug maker Pfizer is now trying to strike a deal with its 1700 employees at...
      Pillar Biosciences enters strategic partnership with China Biotech Services Holdings

      Pillar Biosciences enters strategic partnership with China Biotech Services Holdings

      Farhat Nasim14 Jan 2019 9:00 AM IST
      Under the terms of the agreement, Pillar Biosciences will create a joint venture company with CBSH's subsidiary Central Laboratory (Holdings) Limited...
      Import of drugs in India: Center adds two more ports, Releases Gazette Notification

      Import of drugs in India: Center adds two more ports, Releases Gazette Notification

      Farhat Nasim13 Jan 2019 9:33 AM IST
      New Delhi: An upsurge in the import of drugs is likely to be seen as the government has recently informed about the addition of two new ports for this...
      Healthians to expand in South India, invests Rs 50 crore

      Healthians to expand in South India, invests Rs 50 crore

      Farhat Nasim13 Jan 2019 9:30 AM IST
      "Based on our market survey and customer demand, South India is our first move for a mega expansion planned in 2019," Deepak Sahni, Founder and CEO of...
      Abbott to work to end Malaria in Odisha

      Abbott to work to end Malaria in Odisha

      Farhat Nasim13 Jan 2019 9:15 AM IST
      In collaboration with Malaria No More and the government of Odisha, Abbott is supplying 1 million rapid diagnostic tests (RDTs) and technical...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok